Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

Study reveals investigational drug as effective treatment for relapsed marginal zone lymphoma

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope exhibits current studies and data on cancer therapies at AACR

Researchers report promising results of potential reversal agent

Researchers report promising results of potential reversal agent

Antibody-drug conjugate effectively targets surface protein in childhood neuroblastomas

Antibody-drug conjugate effectively targets surface protein in childhood neuroblastomas

CAR-T cell therapy could be on the horizon for patients with lupus

CAR-T cell therapy could be on the horizon for patients with lupus

EAF4 module determines physicochemical, biophysical attributes of monoclonal antibodies

EAF4 module determines physicochemical, biophysical attributes of monoclonal antibodies

Study shows precision medicines could aid more breast cancer patients via RNA-targeting

Study shows precision medicines could aid more breast cancer patients via RNA-targeting

Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma

Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma

A new approach towards future treatment of diabetes

A new approach towards future treatment of diabetes

Abcam collaborates with Loulou Foundation to discover new research tools for CDKL5 deficiency disorder

Abcam collaborates with Loulou Foundation to discover new research tools for CDKL5 deficiency disorder

Abcam acquires Calico Biolabs to expand custom services capabilities

Abcam acquires Calico Biolabs to expand custom services capabilities

Investigational Ebola treatment found to be safe in adults

Investigational Ebola treatment found to be safe in adults

Researchers identify marker protein that offers both diagnostic and therapeutic function

Researchers identify marker protein that offers both diagnostic and therapeutic function

Sartorius Stedim Biotech launches NBE product characterization service

Sartorius Stedim Biotech launches NBE product characterization service

Lab-Scale Clarification of Mammalian Cell Cultures Expressing Recombinant Antibodies

Lab-Scale Clarification of Mammalian Cell Cultures Expressing Recombinant Antibodies

Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma

Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma

High-performing MS device reaches new level in characterizing protein impurities

High-performing MS device reaches new level in characterizing protein impurities